amphetamine has been researched along with Disease Exacerbation in 8 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated transition from amphetamine-induced psychosis (AIP) to schizophrenia." | 7.81 | Amphetamine-induced psychosis: Transition to schizophrenia and mortality in a small prospective sample. ( Bramness, JG; Gossop, M; Holm, B; Medhus, S; Mørland, J; Rognli, EB, 2015) |
| "We investigated transition from amphetamine-induced psychosis (AIP) to schizophrenia." | 3.81 | Amphetamine-induced psychosis: Transition to schizophrenia and mortality in a small prospective sample. ( Bramness, JG; Gossop, M; Holm, B; Medhus, S; Mørland, J; Rognli, EB, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Martens, MS | 1 |
| Zurhold, H | 1 |
| Rosenkranz, M | 1 |
| O'Donnell, A | 1 |
| Addison, M | 1 |
| Spencer, L | 1 |
| McGovern, W | 1 |
| Gabrhelík, R | 1 |
| Petruželka, B | 1 |
| Rowicka, M | 1 |
| Liebregts, N | 1 |
| Degkwitz, P | 1 |
| Kaner, E | 1 |
| Verthein, U | 1 |
| Medhus, S | 1 |
| Rognli, EB | 1 |
| Gossop, M | 1 |
| Holm, B | 1 |
| Mørland, J | 1 |
| Bramness, JG | 1 |
| Vonder Haar, C | 1 |
| Lam, FC | 1 |
| Adams, WK | 1 |
| Riparip, LK | 1 |
| Kaur, S | 1 |
| Muthukrishna, M | 1 |
| Rosi, S | 1 |
| Winstanley, CA | 1 |
| Decressac, M | 1 |
| Mattsson, B | 1 |
| Lundblad, M | 1 |
| Weikop, P | 1 |
| Björklund, A | 1 |
| Brown, AW | 1 |
| Bjelke, B | 1 |
| Fuxe, K | 1 |
| Homayoun, H | 1 |
| Moghaddam, B | 1 |
| Goodman, DW | 1 |
| Richfield, EK | 1 |
| Thiruchelvam, MJ | 1 |
| Cory-Slechta, DA | 1 |
| Wuertzer, C | 1 |
| Gainetdinov, RR | 1 |
| Caron, MG | 1 |
| Di Monte, DA | 1 |
| Federoff, HJ | 1 |
1 review available for amphetamine and Disease Exacerbation
| Article | Year |
|---|---|
The consequences of attention-deficit/hyperactivity disorder in adults.
Topics: Achievement; Adult; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder | 2007 |
7 other studies available for amphetamine and Disease Exacerbation
| Article | Year |
|---|---|
Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cr | 2020 |
Amphetamine-induced psychosis: Transition to schizophrenia and mortality in a small prospective sample.
Topics: Amphetamine; Disease Progression; Humans; Norway; Prospective Studies; Psychoses, Substance-Induced; | 2015 |
Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation.
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Amantadine; Amphetamine; Animals; Atomoxetine Hydrochlo | 2016 |
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
Topics: alpha-Synuclein; Amphetamine; Analysis of Variance; Animals; Antiparkinson Agents; Behavioral Sympto | 2012 |
Motor response to amphetamine treatment, task-specific training, and limited motor experience in a postacute animal stroke model.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Disease Models, Animal; Disease Progression | 2004 |
Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine.
Topics: Action Potentials; Adaptation, Physiological; Amphetamine; Amphetamine-Related Disorders; Animals; C | 2006 |
Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; alpha-Synuclein; Amphetamine; Animals; Behavior | 2002 |